Login to Your Account



Financings Roundup

Alnara Founder, Investors Return with Start-up Allena

By Jennifer Boggs
Managing Editor

Wednesday, November 16, 2011
Former executives and investors of Alnara Pharmaceuticals Inc. reunited to launch a new start-up, Allena Pharmaceuticals Inc., and disclosed Wednesday a $15 million Series A round for work on nonsystemic oral protein therapeutics for metabolic and orphan diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription